DAIC

APRIL 3, 2024

The “Pharmacology Program” will cover hot topics in cardiovascular medicine that are key issues that pharmacists, as well as other health care team members, face in managing complex patients. Each session is interactive and includes knowledge check-ins and dedicated time for discussion.

Education 105

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology 105

European Journal of Heart Failure

DECEMBER 22, 2023

gradient ≥30 mmHg at rest or ≥50 mmHg after Valsalva maneuver or exercise) despite pharmacological or non-pharmacological therapy. Results Pharmacological or non-pharmacological therapy resolved LVOTO in 1,044 (61.2%) of the 1,706 HOCM patients under active follow-up, whereas 662 patients (38.8%) had persistent LVOTO.

Cardiomyopathy 40

Cardiomyopathy Pharmacology Atrial Fibrillation Outpatient 40

Journal of the American Heart Association

FEBRUARY 8, 2025

H9c2 cells and neonatal mouse ventricular cardiac myocytes were used as invitro models to investigate the effects of pharmacological MC1R activation on hypertrophyrelated responses. MC1R recessive yellow mice showed blunted hypertrophic response to transverse aortic constrictioninduced pressure overload and exercise training.

Physiology 40

Physiology Pharmacology Aortic Exercise 40

DAIC

JULY 25, 2024

During heart failure progression, the heart steadily loses its ability to respond to increased metabolic demand, and mild exercise soon exceeds the heart’s ability to maintain adequate output. Towards the end stage of the disease, the heart cannot pump enough blood to meet the body’s needs at rest.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

Journal of the American Heart Association

MARCH 7, 2025

for Nterminal proBtype natriuretic peptide) while improving exercise parameters (improved placebocorrected peak oxygen consumption of at least 1.4 BackgroundCardiac myosin inhibitors were recently developed to address the underlying pathophysiology of hypertrophic cardiomyopathy and to improve symptoms and quality of life.

Cardiomyopathy 45

Cardiomyopathy Quality of Life Atrial Fibrillation Pharmacology 45

Heart 2023 Conference

FEBRUARY 25, 2023

Don't let this discourage you if you're new to exercising!! For some people, diet changes and some exercise are completely enough. There are numerous programs available for cases both virtual or in-person options, as well as different nicotine relief and pharmacologic options to help you quit.

Blood Pressure 52

Blood Pressure Cholesterol Heart Disease Exercise 52

DAIC

MAY 9, 2024

New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52

Dr. Sanjay Gupta

OCTOBER 16, 2024

20 patients were asked to do high intensity exercise, 20 to moderate intensity and 20 to a control group and they found that patients who engaged in exercise had better collateral flow indices compared to patients who did not exercise. So this was a quick summary of collateralization.

Heart Attack 52

Heart Attack Heart attacks Exercise Coronary Artery Disease 52

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Lifestyle modifications, including diet, exercise, and smoking cessation, play a crucial role. By 2050, the number of individuals affected by AFib is expected to more than double.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Lifestyle modifications, including diet, exercise, and smoking cessation, play a crucial role. By 2050, the number of individuals affected by AFib is expected to more than double.

AFIB 52

AFIB Atrial Fibrillation Innovation Heart Rhythm 52

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Cardiometabolic Health Congress

JANUARY 3, 2024

These pharmaceutical interventions have emerged as a viable option for individuals who have been struggling with weight management and offer an additional tool alongside other lifestyle modifications such as exercise. These weight loss drugs, however, are not meant to be a standalone solution.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Cardiometabolic Health Congress

JULY 25, 2023

What levels of exercise intensity or duration are beneficial? Compared to the 2008 guidelines, where only exercises or activities that last at least 10 minutes could count towards the 150 minute/week goal, in the 2018 guidelines, any kind of moderate to vigorous physical activity can count toward the weekly goal, regardless of duration.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Dr. Smith's ECG Blog

APRIL 22, 2022

ST-elevation myocardial infarction after pharmacologic persantine stress test in a patient with Wellens’ syndrome. And IF it turned out that despite inducible ischemia ( on Echo and ECG ) at low-level exercise, that this patient did not have any chest pain — then this is the definition of “Silent" Ischemia. Lancet 2015 6.

Chest Pain 52

Chest Pain Ischemia Myocardial Infarction Angina 52

Dr. Smith's ECG Blog

SEPTEMBER 7, 2020

If the rhythm converts and then reverts to tachycardia with either adenosine or electricity, Neither one of those modalities should be attempted until some longer acting pharmacological solution is given. WPW does not always have delta waves on the baseline ECG. This is called "Concealed conduction".

Tachycardia 52

Tachycardia Heart Disease Dysrhythmia Ablation 52

Dr. Sanjay Gupta

MARCH 6, 2022

Pharmacological treatments: These can be divided into 2 groups Medications that improve quality of life (usually by relieving symptoms) and medications that can prolong life. Rehabilitative therapies Physiotherapy, conditioning exercises, mindfulness and yoga can be extremely helpful in terms of improving quality of life.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

Stroke Journal

FEBRUARY 27, 2024

Currently, there are no specific pharmacological treatments for CSVD, and the use of conventional antidementia drugs is not recommended. Exercise has the potential to prevent and mitigate CSVD-related brain damage and improve cognitive function.

Dementia 40

Dementia Exercise Pharmacology Risk Factors 40

Cardiometabolic Health Congress

MAY 10, 2024

Results revealed that women are twice as likely to exhibit myocardial ischemia in response to mental stress compared to traditional stressors like exercise or pharmacologic stress. Combining behavioral and pharmacological treatment is most effective.

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

However, evidence on the effectiveness of exercise training in these patients remains limited. ObjectivesExercise training is a rehabilitative approach to improve cardiac function in patients with myocardial infarction.

Myocardial Infarction 52

Myocardial Infarction Exercise Cardiac Function Pharmacology 52